An interventional study of Laying open and Sinus excision in Pilonidal Sinus, sponsored by Uppsala University. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-10-16.
Sponsored by Uppsala University · Not applicable, Interventional, and Treatment
A pilonidal sinus is a cyst or abscess near or on the natal cleft of the buttocks that often contains hair and skin debris. The condition is common and requires surgery to be cured. Several surgical procedures are described in literature. The most common surgical procedure in Sweden is excision of the sinus followed by suturing the subcutaneous tissue and skin. This method, however, has some problems regarding healing and recidives. Therefore this study is comparing the standard excision procedure to another surgical procedure, laying open. Healing frequency is the main variable, but postoperative pain, sick leave time and patient satisfaction is also measured.
107 studies on the registry are indexed under Pilonidal Sinus; 31 are open to participants now.
This study's enrollment of 80 is close to the median of 80 across 73 interventional studies indexed under Pilonidal Sinus.
Browse Pilonidal Sinus studies →Uppsala University is the lead sponsor of 381 studies on the registry; 84 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Laying open
Procedure: Sinus excision
Laying open Antibiotics Dalacin 300 mg tablets or iv infusion 600 mg
Sinus excision Antibiotics Dalacin tablets 300 mg or iv infusion 600 mg
Healing frequency
Time frame: 12 months
pain according to a visual analogue scale
Time frame: 7 days
scar/wound length
Time frame: 12 months
This study is completed, as verified in Oct 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uppsala University